Reactive Thrombocytosis, or elevated blood platelet counts, may predict underlying disease and mortality risk and has been linked with poorer prognosis in COVID-19 patients. Explore in OTR.
Explore augmented underwriting and the evolving role of the underwriter and the continued importance of human expertise in the future of risk assessment. Learn more.
What would happen if your loved one suffered a serious debilitating illness? Could you weather the storm? Learn more about the vital role of Critical Illness (CI) insurance.
Get an unparalleled perspective on underwriting amid a pandemic with ALU’s comprehensive survey. Look back on how carriers responded and explore the challenges ahead. Learn more.
Consider some surprising facts about winter sport risks, including participation, fatality and mindset trends for underwriters to watch. Read more.
While the medical impact of COVID-19 on survivors is not yet fully understood, history from past outbreaks can impart important lessons. Read more.
Tetrahydrocannabinol (THC) use has increased substantially in the last decade. Curious what the science says about health impacts and mortality implications, and how use and age patterns can guide underwriting decisions? Read more.
As diabetes reaches record levels, could the standard glycated hemoglobin A1c test to detect diabetes also serve as a blood biomarker for mortality? Rethink the purpose of this popular test.
Some are calling it the new addiction of the 21st century. Learn more about the physical and psychological implications of smartphone addiction and how it could impact life and disability insurance applications in OTR.
The face of stroke is younger than ever before. Out of every six strokes occurs in young adults, with stroke hospitalization rates on the rise among patients aged 18-64. Explore the risk factors in OTR.